Ebermann Inga, Lopez Irma, Bitner-Glindzicz Maria, Brown Carolyn, Koenekoop Robert Karel, Bolz Hanno Jörn
Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany.
Genome Biol. 2007;8(4):R47. doi: 10.1186/gb-2007-8-4-r47.
Usher syndrome type 1 (USH1) is the leading cause of deafblindness. In most populations, many private mutations are distributed across the five known USH1 genes. We investigated patients from the French Canadian population of Quebec (approximately 6 million people) that descends from about 8,500 French settlers who colonized the St Lawrence River valley between 1608 and 1759. We hypothesized that founder mutations in USH1 genes exist in this population.
We have genetically characterized 15 patients from different regions of Quebec who were clinically diagnosed as USH1. Of these cases, 60% carried mutations of the USH1C gene, a genetic subtype that is rare outside the Acadian population. We have discovered a founder effect of the c.216G>A mutation, which has previously been designated the 'Acadian allele' because it accounts for virtually all Acadian USH1 cases. It represents 40% of disease alleles in Quebec, and a carrier of c.216G>A was identified in the general population. Mutations in other genes, except CDH23, are very rare.
Based on our findings, approximately 0.5% of congenitally deaf children in Quebec are at risk of developing retinal degeneration due to homozygosity for c.216G>A. Although the Acadians and French Canadians from Quebec are descended from French ancestors, they have always been considered genetically distinct. The genetic conditions common in Quebec are generally not found in Acadians, or they are due to different mutations. Our results, however, show that carriers of the c.216G>A allele haplotype belonged to the early founders of both the Acadian and the Quebec population.
1型Usher综合征(USH1)是导致失聪失明的主要原因。在大多数人群中,许多私人突变分布在五个已知的USH1基因中。我们对来自魁北克法裔加拿大人群(约600万人)的患者进行了研究,该人群源自约8500名法国定居者,他们在1608年至1759年间殖民了圣劳伦斯河谷。我们假设该人群中存在USH1基因的奠基者突变。
我们对来自魁北克不同地区的15名临床诊断为USH1的患者进行了基因特征分析。在这些病例中,60%携带USH1C基因突变,这是一种在阿卡迪亚人群之外罕见的基因亚型。我们发现了c.216G>A突变的奠基者效应,该突变此前被称为“阿卡迪亚等位基因”,因为它几乎占了所有阿卡迪亚USH1病例。它占魁北克疾病等位基因的40%,并且在普通人群中鉴定出了一名c.216G>A携带者。除CDH23外,其他基因的突变非常罕见。
基于我们的研究结果,魁北克约0.5%的先天性失聪儿童因c.216G>A纯合而有发生视网膜变性的风险。尽管阿卡迪亚人和魁北克的法裔加拿大人都源自法国祖先,但他们一直被认为在基因上是不同的。魁北克常见的遗传疾病在阿卡迪亚人中通常不存在,或者是由不同的突变引起的。然而,我们的结果表明,c.216G>A等位基因单倍型的携带者属于阿卡迪亚人和魁北克人群的早期奠基者。